Pharma Focus Asia

Astellas Pharma, BioLabs, and Mitsui Fudosan Collaborate to Enhance Life Science Ecosystems in Japan

Wednesday, October 11, 2023

Astellas, BioLabs, and Mitsui Fudosan have jointly established a memorandum of understanding to enhance the life science ecosystem in Japan.

This collaborative effort between Astellas and Mitsui Fudosan aims to boost the development of the planned life science ecosystem in Tsukuba, Kashiwa-no-ha, and the surrounding regions.

This agreement enables BioLabs to leverage its expertise to ensure smooth facility management in support of Astellas. Moreover, it also aims for a shared vision for laboratories in Tsukuba and Kashiwa-no-ha to become hubs where innovative ideas and specialised knowledge converge, catalysing the advancement of groundbreaking healthcare solutions. 

BioLabs partnership with Astellas and Mitsui Fudosan marks a significant step in the expansion of its global presence in Japan. With a common purpose of hastening the commercialisation of groundbreaking innovations that enhance patient well-being, this collaboration aims for the growth of the life science innovation ecosystem in the Tsukuba area.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024